Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

Core Viewpoint - Establishment Labs Holdings Inc. has submitted Motiva® implants for FDA approval in primary and revision breast reconstruction, expanding its product offerings beyond breast augmentation [1] Company Summary - Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, particularly in breast aesthetics and reconstruction [1] - The company previously received FDA approval for Motiva® implants for breast augmentation on September 27, 2024 [1]